|
1
|
Hayashi T, Kawano O, Sakai H, Ideta R,
Ueta T, Maeda T, Mori E, Yugue I, Takao T, Masuda M, et al: The
potential for functional recovery of upper extremity function
following cervical spinal cord injury without major bone injury.
Spinal Cord. 51:819–822. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cadotte DW and Fehlings MG: Spinal cord
injury: A systematic review of current treatment options. Clin
Orthop Relat Res. 469:732–741. 2011. View Article : Google Scholar :
|
|
3
|
Mortazavi MM, Harmon OA, Adeeb N, Deep A
and Tubbs RS: Treatment of spinal cord injury: A review of
engineering using neural and mesenchymal stem cells. Clin Anat.
28:37–44. 2015. View
Article : Google Scholar
|
|
4
|
Ribeiro-Samy S, Silva NA, Correlo VM, et
al: Development and characterization of a PHB-HV-based 3D scaffold
for a tissue engineering and cell-therapy combinatorial approach
for spinal cord injury regeneration. Macromol Biosci. 13:1576–1592.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kanno H, Pressman Y, Moody A, Berg R, Muir
EM, Rogers JH, Ozawa H, Itoi E, Pearse DD and Bunge MB: Combination
of engineered Schwann cell grafts to secrete neurotrophin and
chondroitinase promotes axonal regeneration and locomotion after
spinal cord injury. J Neurosci. 34:1838–1855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abbasi M, Salehi M, Pasbakhsh P and
Sobhani A: Repair of spinal cord injury by co-transplantation of
embryonic stem cell-derived motor neuron and olfactory ensheathing
cell. J Stem Cells Regen Med. 6:812010.PubMed/NCBI
|
|
7
|
Ji W, Hu S, Zhou J, Wang G, Wang K and
Zhang Y: Tissue engineering is a promising method for the repair of
spinal cord injuries (Review). Exp Ther Med. 7:523–528.
2014.PubMed/NCBI
|
|
8
|
Kapur SK and Katz AJ: Review of the
adipose derived stem cell secretome. Biochimie. 95:2222–2228. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liqing Y, Jia G, Jiqing C, Ran G, Fei C,
Jie K, Yanyun W and Cheng Z: Directed differentiation of motor
neuron cell-like cells from human adipose-derived stem cells in
vitro. Neuroreport. 22:370–373. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu H, Chu Y and Lou G: Fiber-modified
adenovirus can mediate human adipose tissue-derived mesenchymal
stem cell-based anti-angiogenic gene therapy. Biotechnol Lett.
32:1181–1188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu W, Lu G, Wang B, Ma Z and Li Y:
Transfection of BDNF gene promotes bone mesenchymal stem cells to
differentiate into neuron-like cells. Zhong Nan Da Xue Xue Bao Yi
Xue Ban. 37:441–446. 2012.In Chinese. PubMed/NCBI
|
|
12
|
Gao H, Wei M, Wang Y, Wu X and Zhu T:
Differentiation of GDNF and NT-3 dual gene-modified rat bone marrow
mesenchymal stem cells into enteric neuron-like cells. J Huazhong
Univ Sci Technolog Med Sci. 32:87–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ji W, Zhang Y and Hu S: Biocompatibility
study of a silk fibroin-chitosan scaffold with adipose
tissue-derived stem cells in vitro. Exp Ther Med. 6:513–518.
2013.PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen KD: Analysis of
relative gene expression data using real-time quantiative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Madigan NN, McMahon S, O'Brien T,
Yaszemski MJ and Windebank AJ: Current tissue engineering and novel
therapeutic approaches to axonal regeneration following spinal cord
injury using polymer scaffolds. Respir Physiol Neurobiol.
169:183–199. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Silva NA, Salgado AJ, Sousa RA, Oliveira
JT, Pedro AJ, Leite-Almeida H, Cerqueira R, Almeida A, Mastronardi
F, Mano JF, et al: Development and characterization of a novel
hybrid tissue engineering-based scaffold for spinal cord injury
repair. Tissue Eng Part A. 16:45–54. 2010. View Article : Google Scholar
|
|
17
|
Zhou J, Lu P, Ren H, Zheng Z, Ji J, Liu H,
Jiang F, Ling S, Heng BC, Hu X and Ouyang H: 17β-estradiol protects
human eyelid-derived adipose stem cells against cytotoxicity and
increases transplanted cell survival in spinal cord injury. J Cell
Mol Med. 18:326–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ren Y, Wu H, Ma Y, Cang M, Wang R and Liu
D: Isolation, cultivation and identification of adipose-derived
stem cell in bovines. Sheng Wu Gong Cheng Xue Bao. 26:1645–1651.
2010.In Chinese.
|
|
19
|
Gibbons A, Wreford N, Pankhurst J and
Bailey K: Continuous supply of the neurotrophins BDNF and NT-3
improve chick motor neuron survival in vivo. Int J Dev Neurosci.
23:389–396. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Gu J, Wang J, Feng X, Tao Y, Jiang
B, He J, Wang Q, Yang J, Zhang S, et al: BDNF and NT-3 expression
by using glucocorticoid-induced bicistronic expression vector
pGC-BDNF-IRES-NT3 protects apoptotic cells in a cellular injury
model. Brain Res. 1448:137–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sobue G, Yamamoto M, Doyu M, Li M, Yasuda
T and Mitsuma T: Expression of mRNAs for neurotrophins (NGF, BDNF,
and NT-3) and their receptors (p75NGFR, trk, trkB, and trkC) in
human peripheral neuropathies. Neurochem Res. 23:821–829. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Islam O, Loo TX and Heese K: Brain-derived
neurotrophic factor (BDNF) has proliferative effects on neural stem
cells through the truncated TRK-B receptor, MAP kinase, AKT and
STAT-3 signaling pathways. Curr Neurovasc Res. 6:42–53. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang YQ, Zeng X, He LM, Ding Y, Li Y and
Zeng YS: NT-3 gene modified Schwann cells promote TrkC gene
modified mesenchymal stem cells to differentiate into neuron-like
cells in vitro. Anat Sci Int. 85:61–67. 2010. View Article : Google Scholar
|
|
24
|
Hapner SJ, Nielsen KM, Chaverra M, Esper
RM, Loeb JA and Lefcort F: NT-3 and CNTF exert dose-dependent,
pleio-tropic effects on cells in the immature dorsal root ganglion:
Neuregulin-mediated proliferation of progenitor cells and neuronal
differentiation. Dev Biol. 297:182–197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Francis N, Farinas I, Brennan C,
Rivas-Plata K, Backus C, Reichardt L and Landis S: NT-3, like NGF,
is required for survival of sympathetic neurons, but not their
precursors. Dev Biol. 210:411–427. 1999. View Article : Google Scholar : PubMed/NCBI
|
